Direkt zum Inhalt Direkt zur Suche Direkt zur Navigation
Information

Coordinator

Prof. Clemens Schmitt

  • Director of the Molekulares Krebsforschungszentrum
  • Leading Consultant of the Haematology and Oncology Department at the Charité

Website of BSIO Berlin School of Integrative Oncology

Humboldt-Universität zu Berlin - Excellence Initiative

Humboldt-Universität zu Berlin | Excellence Initiative | Graduate Schools | Berlin School of Integrative Oncology

Berlin School of Integrative Oncology (BSIO)

With 1.45 million people currently affected in Germany and 450,000 new cases diagnosed each year, cancer is one of the principal challenges facing medicine and our society today. Cancer research, both with regard to its molecular foundations and to finding new methods of treatment therefore constitutes a major research focus at Charité - Universitätsmedizin Berlin, which serves as the joint department of medicine of Freie Universität Berlin and Humboldt-Universität zu Berlin. (Joint proposal submitted by Charité - Universitätsmedizin Berlin in cooperation with its two parent universities, Humboldt-Universität zu Berlin and Freie Universität Berlin)

Under the direction of Professor Clemens Schmitt, Director of the Molekulares Krebsforschungszentrum and Leading Consultant of the Haematology and Oncology Department at the Charité, the Charité is submitting a joint proposal with Humboldt-Universität, Freie Universität, and the non-university partner institutes Max Planck Institute for Molecular Genetics, Max Planck Institute of Molecular Plant Physiology and Max Delbrück Center for Molecular Medicine, for the establishment of a Graduate School to be called the Berlin School of Integrative Oncology (BSIO).

The 25 scientists and scholars in the BSIO planning group, who come from the fields of haematology, oncology, genetics, biochemistry, surgery, radiology, computer science, the social sciences and the humanities, are working on a strongly interdisciplinary concept to provide young doctors and future molecular oncologists with the theoretical background and practical experience they need to develop new methods for the diagnosis and treatment of cancer.

The close communication between life sciences research and clinical application has the advantage of accelerating the development of new forms of treatment for patients and ensuring that experimental research in the laboratory gives top priority to the most urgent problems in the clinical treatment of cancer.

This comprehensive concept for training outstanding young scientists from the very outset of their career will provide the foundation for interdisciplinary research that is equipped to develop effective strategies to tackling the challenge presented by cancer as fast as possible.